Per Soelberg Sørensen

Per Soelberg Sørensen

Professor emeritus, Professor, emeritus


  1. 2024
  2. Published

    Managing multiple sclerosis in individuals aged 55 and above: a comprehensive review

    Fernández, Ó., Sørensen, Per Soelberg, Comi, G., Vermersch, P., Hartung, H. P., Leocani, L., Berger, T., Van Wijmeersch, B. & Oreja-Guevara, C., 2024, In: Frontiers in Immunology. 15, 24 p., 1379538.

    Research output: Contribution to journalReviewResearchpeer-review

  3. Accepted/In press

    Torben Fog – A Danish pioneer in a multi-faceted spectrum of multiple sclerosis research

    Sørensen, Per Soelberg, Bramow, S., Magyari, M., Werdelin, L., Koch-Henriksen, N., Vermersch, P. & Sellebjerg, Finn Thorup, 2024, (Accepted/In press) In: Multiple Sclerosis Journal. 7 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. 2023
  5. Published

    An update on combination therapies for multiple sclerosis: where are we now?

    Sørensen, Per Soelberg, Magyari, Melinda & Sellebjerg, Finn Thorup, 2023, In: Expert Review of Neurotherapeutics. 23, 12, p. 1173-1187 15 p.

    Research output: Contribution to journalReviewResearchpeer-review

  6. Published

    Autologous hematopoietic stem cell transplantation of patients with aggressive relapsing-remitting multiple sclerosis: Danish nation-wide experience

    Jespersen, F., Petersen, S. L., Andersen, P., Sellebjerg, Finn Thorup, Magyari, M., Sørensen, Per Soelberg & Blinkenberg, M., 2023, In: Multiple Sclerosis and Related Disorders. 76, 7 p., 104829.

    Research output: Contribution to journalJournal articleResearchpeer-review

  7. Published

    Autonomic response to walk tests is useful for assessing outcome measures in people with multiple sclerosis

    the RADAR-CNS Consortium, T. R. C., 2023, In: Frontiers in Physiology. 14, 1145818.

    Research output: Contribution to journalJournal articleResearchpeer-review

  8. Published

    Heterogeneity on long-term disability trajectories in patients with secondary progressive MS: a latent class analysis from Big MS Data network

    Signori, A., Lorscheider, J., Vukusic, S., Trojano, M., Iaffaldano, P., Hillert, J., Hyde, R., Pellegrini, F., Magyari, M., Koch-Henriksen, N., Sørensen, P. S., Spelman, T., Van Der Walt, A., Horakova, D., Havrdova, E., Girard, M., Eichau, S., Grand'maison, F., Gerlach, O., Terzi, M. & 18 others, Ozakbas, S., Skibina, O., Van Pesch, V., Sa, M. J., Prevost, J., Alroughani, R., McCombe, P. A., Gouider, R., Mrabet, S., Castillo-Trivino, T., Zhu, C., De Gans, K., Sánchez-Menoyo, J. L., Yamout, B., Khoury, S., Sormani, M. P., Kalincik, T. & Butzkueven, H., 2023, In: Journal of Neurology, Neurosurgery and Psychiatry. 94, 1, p. 23-30 8 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  9. Published

    Natalizumab treatment of multiple sclerosis — a Danish nationwide study with 13 years of follow-up

    Buron, M. D., Christensen, J. R., Pontieri, L., Joensen, H., Kant, M., Rasmussen, P. V., Sellebjerg, Finn Thorup, Sørensen, Per Soelberg, Bech, D. & Magyari, M., 2023, In: Multiple Sclerosis and Related Disorders. 74, 9 p., 104713.

    Research output: Contribution to journalJournal articleResearchpeer-review

  10. Published

    NfL and GFAP in serum are associated with microstructural brain damage in progressive multiple sclerosis

    Ammitzbøll, C., Dyrby, T. B., Börnsen, L., Schreiber, K., Ratzer, R., Romme Christensen, J., Iversen, P., Magyari, M., Lundell, H., Jensen, P. E. H., Sørensen, Per Soelberg, Siebner, Hartwig Roman & Sellebjerg, Finn Thorup, 2023, In: Multiple Sclerosis and Related Disorders. 77, 8 p., 104854.

    Research output: Contribution to journalJournal articleResearchpeer-review

  11. Published

    Real-world experience of cladribine treatment in relapsing-remitting multiple sclerosis: A Danish nationwide study

    Sørensen, Per Soelberg, Pontieri, L., Joensen, H., Heick, A., Rasmussen, P. V., Schäfer, J., Ratzer, R., Pihl, C. E., Sellebjerg, Finn Thorup & Magyari, M., 2023, In: Multiple Sclerosis and Related Disorders. 70, 9 p., 104491.

    Research output: Contribution to journalJournal articleResearchpeer-review

  12. Published

    The gut microbiota in multiple sclerosis varies with disease activity

    Thirion, F., Sellebjerg, Finn Thorup, Fan, Yong, Lyu, Liwei, Hansen, T. H., Pons, N., Levenez, F., Quinquis, B., Stankevic, Evelina, Søndergaard, H. B., Dantoft, T. M., Poulsen, C. S., Forslund, S. K., drb459, drb459, Hansen, Torben, Brix, S., Oturai, A., Sørensen, Per Soelberg, Ehrlich, S. D. & Pedersen, Oluf Borbye, 2023, In: Genome Medicine. 15, 17 p., 1.

    Research output: Contribution to journalJournal articleResearchpeer-review

  13. Published

    The peripheral endocannabinoid system and its association with biomarkers of inflammation in untreated patients with multiple sclerosis

    Gustavsen, S., Olsson, A., Oturai, A. B., Linnet, Kristian, Thomsen, Ragnar, Rasmussen, Brian Schou, Jørgensen, Christian Falck, Langkilde, Annika Reynberg, Sørensen, Per Soelberg, Sellebjerg, Finn Thorup & Søndergaard, H. B., 2023, In: European Journal of Neurology. 30, 10, p. 3212-3220

    Research output: Contribution to journalJournal articleResearchpeer-review

  14. 2022
  15. Published

    Fitbeat: COVID-19 estimation based on wristband heart rate using a contrastive convolutional auto-encoder

    Liu, S., Han, J., Puyal, E. L., Kontaxis, S., Sun, S., Locatelli, P., Dineley, J., Pokorny, F. B., Dalla Costa, G., Leocani, L., Guerrero, A. I., Nos, C., Zabalza, A., Sorensen, P. S., Buron, M., Magyari, M., Ranjan, Y., Rashid, Z., Conde, P., Stewart, C. & 10 others, Folarin, A. A., Dobson, R. J. B., Bailon, R., Vairavan, S., Cummins, N., Narayan, V. A., Hotopf, M., Comi, G., Schuller, B. & RADAR-CNS Consortium, R. C., Mar 2022, In: Pattern Recognition. 123, 10 p., 108403.

    Research output: Contribution to journalJournal articleResearchpeer-review

  16. Published

    Antidrug Antibodies Against Biological Treatments for Multiple Sclerosis

    Sørensen, Per Soelberg, 2022, In: CNS Drugs. 36, 6, p. 569-589 21 p.

    Research output: Contribution to journalReviewResearchpeer-review

  17. Published

    Biopsychosocial Response to the COVID-19 Lockdown in People with Major Depressive Disorder and Multiple Sclerosis

    Siddi, S., Giné-Vázquez, I., Bailon, R., Matcham, F., Lamers, F., Kontaxis, S., Laporta, E., Garcia, E., Arranz, B., Dalla Costa, G., Guerrero, A. I., Zabalza, A., Buron, M. D., Comi, G., Leocani, L., Annas, P., Hotopf, M., Penninx, B. W. J. H., Magyari, M., Sørensen, P. S. & 27 others, Montalban, X., Lavelle, G., Ivan, A., Oetzmann, C., White, K. M., Difrancesco, S., Locatelli, P., Mohr, D. C., Aguiló, J., Narayan, V., Folarin, A., Dobson, R. J. B., Dineley, J., Leightley, D., Cummins, N., Vairavan, S., Ranjan, Y., Rashid, Z., Rintala, A., Girolamo, G. D., Preti, A., Simblett, S., Wykes, T., Myin-Germeys, I., Haro, J. M., PAB Members, P. M. & on behalf of the RADAR-CNS consortium, O. B. O. T. R. C., 2022, In: Journal of Clinical Medicine. 11, 23, 7163.

    Research output: Contribution to journalJournal articleResearchpeer-review

  18. Published

    Impact of methodological choices in comparative effectiveness studies: application in natalizumab versus fingolimod comparison among patients with multiple sclerosis

    Lefort, M., Sharmin, S., Andersen, J. B., Vukusic, S., Casey, R., Debouverie, M., Edan, G., Ciron, J., Ruet, A., De Sèze, J., Maillart, E., Zephir, H., Labauge, P., Defer, G., Lebrun-Frenay, C., Moreau, T., Berger, E., Clavelou, P., Pelletier, J., Stankoff, B. & 68 others, Gout, O., Thouvenot, E., Heinzlef, O., Al-Khedr, A., Bourre, B., Casez, O., Cabre, P., Montcuquet, A., Wahab, A., Camdessanché, J. P., Maurousset, A., Ben Nasr, H., Hankiewicz, K., Pottier, C., Maubeuge, N., Dimitri-Boulos, D., Nifle, C., Laplaud, D. A., Horakova, D., Havrdova, E. K., Alroughani, R., Izquierdo, G., Eichau, S., Ozakbas, S., Patti, F., Onofrj, M., Lugaresi, A., Terzi, M., Grammond, P., Grand’Maison, F., Yamout, B., Prat, A., Girard, M., Duquette, P., Boz, C., Trojano, M., McCombe, P., Slee, M., Lechner-Scott, J., Turkoglu, R., Sola, P., Ferraro, D., Granella, F., Shaygannejad, V., Prevost, J., Maimone, D., Skibina, O., Buzzard, K., Van der Walt, A., Karabudak, R., Van Wijmeersch, B., Csepany, T., Spitaleri, D., Vucic, S., Koch-Henriksen, N., Sellebjerg, Finn Thorup, Sørensen, Per Soelberg, Hilt Christensen, C. C., Rasmussen, P. V., Jensen, Michael Broksgaard, Frederiksen, J. L., Bramow, S., Mathiesen, H. K., Schreiber, K. I., Butzkueven, H., Magyari, M., Kalincik, T. & Leray, E., 2022, In: BMC Medical Research Methodology. 22, 1, 14 p., 155.

    Research output: Contribution to journalJournal articleResearchpeer-review

  19. Published

    Population Pharmacokinetic–B Cell Modeling for Ofatumumab in Patients with Relapsing Multiple Sclerosis

    Yu, H., Graham, G., David, O. J., Kahn, J. M., Savelieva, M., Pigeolet, E., Das Gupta, A., Pingili, R., Willi, R., Ramanathan, K., Kieseier, B. C., Häring, D. A., Bagger, M. & Sørensen, Per Soelberg, 2022, In: CNS Drugs. 36, 3, p. 283-300 18 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  20. Published

    The risk of infections for multiple sclerosis and neuromyelitis optica spectrum disorder disease-modifying treatments: Eighth European Committee for Treatment and Research in Multiple Sclerosis Focused Workshop Review. April 2021

    Tur, C., Dubessy, A. L., Otero-Romero, S., Amato, M. P., Derfuss, T., Di Pauli, F., Iacobaeus, E., Mycko, M., Abboud, H., Achiron, A., Bellinvia, A., Boyko, A., Casanova, J. L., Clifford, D., Dobson, R., Farez, M. F., Filippi, M., Fitzgerald, K. C., Fonderico, M., Gouider, R. & 29 others, Hacohen, Y., Hellwig, K., Hemmer, B., Kappos, L., Ladeira, F., Lebrun-Frénay, C., Louapre, C., Magyari, M., Mehling, M., Oreja-Guevara, C., Pandit, L., Papeix, C., Piehl, F., Portaccio, E., Ruiz-Camps, I., Selmaj, K., Simpson-Yap, S., Siva, A., Sørensen, Per Soelberg, Sormani, M. P., Trojano, M., Vaknin-Dembinsky, A., Vukusic, S., Weinshenker, B., Wiendl, H., Winkelmann, A., Zuluaga Rodas, M. I., Tintoré, M. & Stankoff, B., 2022, In: Multiple Sclerosis Journal. 28, 9, p. 1424-1456 33 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  21. Published

    The utility of wearable devices in assessing ambulatory impairments of people with multiple sclerosis in free-living conditions

    Sun, S., Folarin, A. A., Zhang, Y., Cummins, N., Liu, S., Stewart, C., Ranjan, Y., Rashid, Z., Conde, P., Laiou, P., Sankesara, H., Dalla Costa, G., Leocani, L., Sørensen, P. S., Magyari, M., Guerrero, A. I., Zabalza, A., Vairavan, S., Bailon, R., Simblett, S. & 8 others, Myin-Germeys, I., Rintala, A., Wykes, T., Narayan, V. A., Hotopf, M., Comi, G., Dobson, R. J. & RADAR-CNS Consortium, R. C., 2022, In: Computer Methods and Programs in Biomedicine. 227, 107204.

    Research output: Contribution to journalJournal articleResearchpeer-review

  22. 2021
  23. Published

    Age and sex as determinants of treatment decisions in patients with relapsing-remitting MS

    Sørensen, Per Soelberg, Kopp, T. I., Joensen, H., Olsson, A., Sellebjerg, Finn Thorup & Magyari, M., 2021, In: Multiple Sclerosis and Related Disorders. 50, 102813.

    Research output: Contribution to journalJournal articleResearchpeer-review

  24. Published

    Cardiovascular Safety of Degarelix Versus Leuprolide in Patients With Prostate Cancer: The Primary Results of the PRONOUNCE Randomized Trial

    Lopes, R. D., Higano, C. S., Slovin, S. F., Nelson, A. J., Bigelow, R., Sørensen, Per Soelberg, Melloni, C., Goodman, S. G., Evans, C. P., Nilsson, J., Bhatt, D. L., Clarke, N. W., Olesen, T. K., Doyle-Olsen, B. T., Kristensen, H., Arney, L., Roe, M. T., Alexander, J. H. & PRONOUNCE Study Investigators, P. S. I., 2021, In: Circulation. 144, 16, p. 1295-1307 13 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  25. Published

    Dimethyl Fumarate Treatment in Patients With Primary Progressive Multiple Sclerosis: A Randomized, Controlled Trial

    Højsgaard Chow, H., Talbot, J., Lundell, H., Gøbel Madsen, C., Marstrand, L., Lange, Theis, Mahler, M. R., Buhelt, S., Hansen, Rikke Holm, Blinkenberg, M., Romme Christensen, J., Sørensen, Per Soelberg, von Essen, Marina Rode, Siebner, Hartwig Roman & Sellebjerg, Finn Thorup, 2021, In: Neurology(R) neuroimmunology & neuroinflammation. 8, 5, p. 1-10

    Research output: Contribution to journalJournal articleResearchpeer-review

  26. Published

    Early treatment delays long-term disability accrual in RRMS: Results from the BMSD network

    Iaffaldano, P., Lucisano, G., Butzkueven, H., Hillert, J., Hyde, R., Koch-Henriksen, N., Magyari, M., Pellegrini, F., Spelman, T., Sørensen, Per Soelberg, Vukusic, S. & Trojano, M., 2021, In: Multiple Sclerosis Journal. 27, 10, p. 1543-1555 13 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  27. Published

    Editorial: Challenges in the diagnosis and treatment of multiple sclerosis

    Sørensen, Per Soelberg, 2021, In: Current Opinion in Neurology. 34, 3, p. 275-276 2 p.

    Research output: Contribution to journalEditorialResearchpeer-review

  28. Published

    Exposure to passive smoking during adolescence is associated with an increased risk of developing multiple sclerosis

    Oturai, D. B., Bach Søndergaard, H., Koch-Henriksen, N., Andersen, C., Laursen, J. H., Gustavsen, S., Kristensen, J. T., Magyari, M., Sørensen, Per Soelberg, Sellebjerg, Finn Thorup, Thørner, L. W., Ullum, H. & Oturai, A. B., 2021, In: Multiple Sclerosis Journal. 27, 2, p. 188-197 10 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  29. Published

    Highly effective disease-modifying treatment as initial MS therapy

    Schmierer, K., Sørensen, Per Soelberg & Baker, D., 2021, In: Current Opinion in Neurology. 34, 3, p. 286-294 9 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

Previous 1 2 3 4 5 6 7 8 ...11 Next

ID: 11025